FIELD: medicine.
SUBSTANCE: are described medical implants which release anthracycline, fluoropyrimidine, antagonist of folic acid, podophyllotoxin, camptotecine, hydroxyurea or platinum complex.
EFFECT: suppressed or reduced rate of implant-associated infections.
83 cl, 1 dwg, 2 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF MITOXANTHRON LIPOSOME FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMA | 2019 |
|
RU2804477C2 |
INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
APPLICATION OF ALLOPURINOL FOR TREATING PALMOPLANTAR ERYTHRODYSESTHESIA | 2007 |
|
RU2438673C2 |
IMPROVED DRUG-COATED MEDICAL DEVICES, MAKING AND USING THEM | 2008 |
|
RU2471508C2 |
ELECTRON BEAM STERILISED MEDICAL DEVICE WITH BIOACTIVE COATING | 2010 |
|
RU2591829C2 |
ENDOPROSTHESIS, COATED WITH ACTIVE COMPOUND | 2012 |
|
RU2592367C2 |
NANOPARTICLES CARRYING CHEMOTHERAPEUTIC ANTI-CANCER THERAPEUTIC AGENT | 2012 |
|
RU2616494C2 |
METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES | 2011 |
|
RU2602878C2 |
METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
Authors
Dates
2008-12-20—Published
2003-05-27—Filed